Coronary angioplasty in patients with severe left ventricular dysfunction  by Kohli, Ravinder S. et al.
lACC Vol. 16. No.4
October 1990:807-11
Coronary Angioplasty in Patients With Severe Left
Ventricular Dysfunction
RAVINDER S. KOHLI, MD, DM, GERMANO DISCIASCIO, MD, FACC,
MICHAEL J. COWLEY, MD, FACC, AMAR NATH, MD, FACC, EVELYNE GOUDREAU, MD,
GEORGE W. VETROVEC, MD, FACC
Richmond, Virginia
807
The applications for coronary angioplasty have greatly
expanded and the procedure is now increasingly used in
complex and potentially high risk conditions. This report
describes the short· and long·term effects of coronary
angioplasty in 61 patients with severely depressed left
ventricular function (ejection fraction ~35%) with unstable
or refractory anginal symptoms, or both, in whom revas-
cularization was necessary despite increased risk.
In a retrospective analysis of 1,260 patients under-
going angioplasty between January 1985 through
December 1987, 61 had an ejection fraction ~35%. The
common clinical presentation was unstable angina (70%)
with or without recent myocardial infarction. Mean left
ventricular ejection fraction was 27 ± 6%. Forty-five
patients (74%) had multivessel disease. Clinical success
after angioplasty was achieved in 55 patients (90%). Major
complications (death, infarction and emergency bypass
Coronary angioplasty has evolved from a procedure carried
out in selected patients with single vessel coronary disease
(l,2) to an effective alternative to coronary artery bypass
graft surgery in widely different patient groups. including
those with multivessel coronary disease (3-5), the elderly (6)
and those with poor left ventricular function (7). Decisions
regarding surgery versus coronary angioplasty are made to
select a therapy with the least potential for morbidity and
mortality and with the highest probability of short- and
long-term success. In certain patients considered poor can-
didates for coronary artery bypass surgery, coronary angio-
plasty has been attempted as a revascularization alternative
particularly for those with depressed left ventricular func-
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surgery) occurred in five patients (8.2%), with death in two
(3.2%).
During long-term (mean 21 ± 11 months) follow-up
study of the 55 patients with successful angioplasty, 13
(23%) died, including 3 of noncardiac causes, and 11 (20%)
had clinically symptomatic recurrence. Continued clinical
success was present in 39 patients (71 %), of whom 28 (51 %)
were event·free patients and 11 (20%) had clinical recur·
rence; a successful second angioplasty procedure was per-
formed in 9 because of restenosis.
Thus, in patients with depressed left ventricular func·
tion, coronary angioplasty can be performed with a short·
term success rate comparable to that of routine angioplasty
or surgical procedures, However, acute complications are
more frequent and the late mortality rate is higher than in
patients with less depressed function.
(J Am Coli CardioI1990j16:807-11)
tion. In this study, we review the results of coronary
angioplasty in patients with severely depressed left ventric-
ular function who were considered poor surgical candidates.
Methods
Study patients. Between January I, 1985 and December
31, 1987, 61 patients with an angiographic left ventricular
ejection fraction ~35% underwent coronary angioplasty.
These patients were considered to be at higher risk for
surgical revascularization and coronary angioplasty was
offered as an alternative. In most cases, the decision was
arrived at after joint review of the angiograms with the
cardiac surgeons. All patients had severe ischemic symp-
toms and myocardium at jeopardy, prompting consideration
for revascularization despite increased risk. All patients
undergoing angioplasty had a lesion in at least one major
vessel potentially amenable to angioplasty.
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Success
Table 2. Vessels and Lesions Dilated
CABG = coronary artery bypass graft surgery; CAD = coronary artery
disease; LVEF = left ventricular ejection fraction; Ml = myocardial infarc-
tion.
No. No. %
Vessels 88 81 92
Lesions 121 109 90
Patients 61 55 90
%
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59 ± 15
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47
18
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Age (yr)
Mean
Range
Gender (male)
Stable angina
Unstable angina
Remote MI (> 15 days old)
Recent MI «15 days old)
Previous CABG
Extent of CAD
Single vessel
Double vessel
Triple vessel
LVEF (%)
Mean
Range
LVEF :s20%
Table 1. Clinical Characteristics of 61 Patients
disease. 24 (39%) had double vessel disease and 21 (35%) had
triple vessel disease. Total occlusion of at least one vessel
was observed in 11 patients (18%). Mean left ventricular
ejection fraction was 27 ± 6% (range 9% to 35%); in 12
patients (20%), the ejection fraction was ~20%.
Immediate success (Table 2). A total of 88 vessels were
dilated; 5 were dilated in one patient. 4 in two patients and 3
in three patients. Dilation of 121 lesions in the 88 vessels was
attempted and these included 1 lesion in 30 patients, 2 in 16
patients, 3 in 7 patients, 4 in 4 patients. 5 in 2 patients and 6
in 2 patients.
Success was achieved in 109 (90%) of the 121 lesions in
which dilation was attempted. Successful dilation was
achieved in 81 (92%) of the 88 vessels dilated. Clinical
success was achieved in 55 patients (90%).
Complications (Table 3). One or more major complica-
tions were observed in five patients (8.2%) and included two
deaths (3.2%) and four myocardial infarctions (6.4%); of
these. two were Q wave and two were non-Q wave infarc-
tions. One of the former patients died in the hospital. Left
ventricular ejection fraction in the two patients who died was
25% and 23%. respectively. No patient required emergency
coronary artery bypass graft surgery.
Angioplasty protocol. Angioplasty was performed by
standard technique (4,5), with patients receiving aspirin (325
mg daily) and frequently dipyridamole (150 mg daily) and a
calcium channel antagonist before and until 6 months after
the procedure. Intravenous heparin (usually a 10,000 U
bolus injection with periodic supplements) was given to all
patients. Intracoronary nitroglycerin was used for significant
ischemia or suspected coronary spasm, or both. Intraaortic
balloon augmentation was instituted prophylactically in one
patient but was available for use in all if hemodynamic
support was required; a circulatory assist device was not
used in any patient. Lesion severity was determined by
visual assessment with consensus agreement by two experi-
enced angiographers. In patients with multivessel disease,
lesions thought to be responsible for symptoms or ischemia.
or both. were dilated first.
Definitions. Angiographic success was defined as a ?:20%
increase in luminal diameter. with a residual narrowing
~50%. Clinical success was achieved if there was improve-
ment by at least one anginal class or achievement of an
asymptomatic state with angiographic success. Complica-
tions were recorded and defined as previously described (8);
they were defined as major when death, myocardial infarc-
tion or emergency coronary artery bypass graft surgery
occurred. Clinical recurrence was defined as a return of
symptoms or signs of ischemia. or both, accompanied by
angiographic evidence of restenosis of one or more lesions,
with or without the appearance of new lesions.
Follow-up. All patients were followed up by return visit
or telephone contact or by obtaining physician records to
determine recurrence of clinical symptoms or death. Actu-
arial life table analyses (9) were utilized for specific fol-
lOW-Up events (death, repeat revascularization and myocar-
dial infarction).
Statistics. Statistical analysis was performed by using the
chi-square test for discrete variables and t test for continu-
ous variables. A p value <0.05 was considered significant.
Data are reported as mean values ± SD.
Results
Clinical characteristics (Table 1). During the 36 month
study period, 1.260 new patients underwent coronary angio-
plasty at the Medical College of Virginia. Sixty-one (5%) of
these patients had a left ventricular ejection fraction <35%.
There were 47 men (77%) and 14 women (23%), ranging in
age from 19 to 83 years (mean 59 ± 15). Forty-three (70%)
had unstable angina and 18 (30%) had limiting stable angina
unresponsive to medical treatment; 37 (61%) had previous
myocardial infarction and 24 (39%) of these had recent
myocardial infarction « 15 days old); and 12 (20%) had
previous coronary bypass surgery.
Angiographic characteristics (Table 1). On coronary angi-
ography, 16 patients (26%) had significant single vessel
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Table 3. Complications During Coronary Angioplasty
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Other complications occurred in five patients (8.2%).
These included transient complete heart block in one (2%),
hypotension requiring intraaortic balloon augmentation in
two (3%), groin hematoma in one (2%). acute renal tubular
necrosis in one (2%) and femoral artery pseudoaneurysm in
one (2%).
Follow-up (Table 4). Follow-up study> I year was avail-
able in all 55 patients in whom clinical success was achieved;
the mean follow-up period was 21 ± II months (range 11.6 to
45). Clinical recurrence of angina was seen in II patients
(20%). Repeat angioplasty was successfully attempted in
nine of these patients I to 19.4 months (mean 9.4 ± 6) after
the initial procedure; one of the nine required a third
angioplasty. Two other patients (4%) with clinical recur-
rence had successful coronary bypass surgery 6 and 40
months, respectively, (mean 22.8 ± 24.2) after angioplasty.
Another two patients (4%) had angioplasty performed in
areas of new disease 4 and 19 months after the original
procedure. One patient (2%) had a late cardiac transplant
because of worsening heart failure.
Thirteen patients (23%) have died. including 10 patients
who died of cardiac causes (sudden cardiac death) and 3 of
Figure l. Actuarial survival curve showing the survival trends in 55
patients with severe left ventricular dysfunction who underwent
successful angioplasty.
noncardiac causes. One of the former included a patient who
had developed a Q wave myocardial infarction during the
initial procedure. Death occurred 1.9 to 31 months (mean 10
± 8) after the original procedure. The patients who died of
cardiac causes during the follow-up period had an initial left
ventricular ejection fraction of 16% to 35% (mean 25.6 ±
6%), which was not significantly different from that of the
entire group (27 ± 6%). No patient had a nonfatal myocardial
infarction during the follow-up period.
The actuarial survival rate was 77% at 24 months (Fig. 1)
and the event-free survival rate (free of repeat angioplasty
[Fig. 2] or bypass surgery [Fig. 3]) was 63% and 75%,
respectively. at 18 months.
Figure 2. Event-free survival in 55 patients after taking into account
death. angioplasty for restenosis and myocardial infarction.
Table 4. Follow-Up Data in 55 Patients
Follow-up (mo.) LOrMean 21.0 ± II
Range 11.6 to 45
Clinical recurrence 11 (20'7c) E
! \,,,Repeat angioplasty 9 vCABG E2 N
Angioplasty (new disease) 2 (4'7c) T
1 \Event free 28 (51'7c1 F
Continued success 39 (71'7c) R IE ~Death 13 (13'7cl E LCardiac 10Noncardiac 3 :Nonfatal MI o(O'7c)Cardiac transplant ~1 (2'7c) 0.5 I I n-29fl:16 I----------l0 6 12 18 24 30 36 42
Abbreviations as in Figure 1. MONTHS
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angioplasty who were enrolled in the National Heart, Lung,
and Blood Institute registry (8,15). The higher mortality rate
may be ascribed to severe hemodynamic deterioration due to
vessel occlusion superimposed on severely depressed myo-
cardial reserve. In patients with depressed left ventricular
function (ejection fraction <40%), the mortality rate re-
ported by Hartzler et at. (16) is 2.7%. Recently, Taylor et at.
(7) noted no intraprocedural deaths in a subset of 12 patients
with depressed left ventricular function. Our series of pa-
tients was different in that Taylor et at. (7) only performed
single vessel dilations. whereas multivessel dilations were
performed in nearly 33% of our patients. The rate of myo-
cardial infarction during the procedure in our series is also
comparable to that seen in patients undergoing routine
coronary angioplasty. We observed an overall myocardial
infarction rate of 6.4%; the nonfatal infarction rate was 4.9%
(three patients), which is comparable to the rate of 4.3%
recently reported (14) from the National Heart. Lung and
Blood Institute's second registry representing contemporary
angioplasty results.
In the report of the second registry (14), emergency
surgical revascularization was needed in 2.9% to 4.3% of
patients undergoing coronary angioplasty, depending on the
number of vessels involved. In our study. no patient under-
went emergency coronary bypass surgery. The cases were
reviewed with the surgical team on standby and it was jointly
decided that surgery could not be performed because of the
hemodynamic status and extent of disease.
Late outcome. In our study. >90% of the patients were
clinically improved. Clinical recurrence was observed in II
patients (20%) and successful repeat dilation was performed
in 9 of these and the remaining 2 patients underwent bypass
surgery. New disease was demonstrated and dilation was
successfully performed in two patients.
The rate of clinical recurrence observed in our study
group appears to be lower than that ofpatients undergoing
routine coronary angioplasty. However, the incidence of
late cardiac death in these patients is significant, with an 18%
incidence rate (10 patients) of sudden cardiac death during
the follow-up period. It is possible that sudden death may
have been a fatal manifestation of restenosis in some or all of
these patients because of minimal cardiac reserve. It is also
possible that this fatal event could be due to presence of
disease in "undilated" arteries. resulting in incomplete
revascularization. However, because the probability of re-
stenosis in the short term is greater than the probability of
progression of native vessel disease, restenosis appears
likely to playa substantial role.
Coronary angioplasty versus bypass surgery. There are no
direct randomized comparative studies between coronary
artery bypass graft surgery and coronary angioplasty in
patients with poor left ventricular function. However, coro-
nary angioplasty in such patients appears to be an acceptable
method of treatment in selected. potentially high risk surgi-
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Figure 3. Event-free survival in 55 patients after taking into account
death, myocardial infarction and surgical revascularization during
the follow-up period.
Discussion
Coronary artery bypass surgery is known to improve
survival in patients with left ventricular dysfunction and
triple vessel disease, but there is an increased risk of
complications (including death) and the operative mortality
rate is 6.9% (10). After bypass surgery, "high risk" patients
seem to have a better survival than medically treated pa-
tients over a 7 to 10 year follow-up period (11.12). Recently,
however, it has been pointed out (12.13) that this improved
survival is not permanent and that the survival curves of
medically and surgically treated patients tend to converge
after 5 years. Comparative long-term survival data are not
available in patients with significantly reduced left ventricu-
lar function who have undergone coronary angioplasty.
In the present study. we attempted to assess both the
immediate and long-term results of coronary angioplasty in
patients with severe left ventricular dysfunction defined as
left ventricular ejection fraction :535% as indicative of
severely depressed left ventricular function. In this group of
patients, coronary bypass surgery was not performed be-
cause the surgical morbidity and mortality risk frequently
appeared equal to or in excess of the predicted risk of
coronary angioplasty in the setting of left ventricular dys-
function. All patients were clearly informed of the issues and
concerns before proceeding. Surgical backup, however. was
available for all patients.
Immediate results. The immediate angiographic and clin-
ical results were comparable with those seen during routine
coronary angioplasty. The major complication rate in our
study was 8.2%, which is higher than that expected in
patients with normal left ventricular function undergoing
angioplasty (8.14,15). Two procedure-related deaths (3.2%)
were encountered in the current study compared with rates
of 0.2% to 2.8% reported in patients undergoing coronary
JACC Vol. 16, No.4
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cal patients. Results of the Coronary Artery Surgery Study
(0) in patients with poor left ventricular function comparing
medical versus surgical treatment revealed that coronary
bypass surgery prolonged survival in patients with evidence
of ischemia. The surgical benefits were most marked in those
patients with a left ventricular ejection fraction :526%. The
5 year survival rate in the medically managed patients with
an ejection fraction <26% was 43% compared with 63% for
surgically treated patients. Our data reveal an actuarial
survival rate of 77% after 2 years in patients after successful
coronary angioplasty. Although patients in the Coronary
Artery Surgery Study (0) had a somewhat better survival
rate, the fact that our study has a much smaller number of
patients makes the two studies not entirely comparable;
however, the results of revascularization in both studies are
broadly similar. Thus, despite a poorer outcome for patients
with depressed cardiac function, revascularization appears
important to decrease subsequent risk.
Complications. Complications of the procedure (particu-
larly death) are more frequent than in patients undergoing
coronary angioplasty with normal cardiac function and the
incidence of sudden death during the follow-up period is
significant, suggesting the need for close follow-up evalua-
tion for any signs and symptoms of early restenosis. Repeat
coronary angiography or nuclear perfusion imaging, or both,
even in the absence of symptoms, as early as 3 months after
initial angioplasty may help detect early asymptomatic re-
stenosis. The possible relation between sudden death and
restenosis is substantiated by our observation that there is a
close relation between the mean time to repeat angioplasty
for restenosis (9.4 ± 6 months) and the mean time to sudden
death 00 ± 8 months).
Conclusions. Our study group of 61 patients was highly
selective in that, in addition to depressed left ventricular
function and a high risk of surgical revascularization, these
patients had one or more lesions that were considered
amenable to angioplasty. The periprocedural mortality rate
is relatively high despite a good initial success rate; in
addition, the high follow-up mortality rate may be a mani-
festation of restenosis overlying a severely compromised
myocardium. Coronary angioplasty in such patients can be
performed with a high degree of immediate success but may
not affect the natural history of these patients, particularly
the late mortality rate. However, early detection of silent
restenosis may be possible by elective repeat angiography or
nuclear perfusion imaging, or both, which could lead to
timely repeat angioplasty and perhaps fewer late deaths. The
study does not demonstrate angioplasty to be a better
method of revascularization than bypass surgery but, rather,
a reasonable and potentially feasible alternative that requires
further investigation to determine subgroups that may be
preferentially treated by one or the other therapy.
We are grateful to Kim Kelly. RN for technical support and Joan Smith for
secretarial assistance.
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